| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_070622b4926092a4a2eefb84caa4fe1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c419906858e635b9c06e115d9e2d37cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b0fb442ef8cd9a7ae5e549d4bfe0792 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate |
2005-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17884b4a4ff1d7bfe426b289a54d0329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a12cf3aee570d154224a2191e230368b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080d8ccf1be21009e60e8f88e8178e30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d1f97a2adf72eb22d2b981e3a1b7da3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe026d2d27b2381a13e4cc582be6191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db2f4802c54d27846bdd5651527b901c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74b793c1e05f39eaf157d06ce2bf5425 |
| publicationDate |
2007-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20070005804-A |
| titleOfInvention |
Genetic Polymorphism in the Transition Growth Factor Beta-Induced Gene Associated with Body Obesity Index |
| abstract |
The present invention relates to genetic polymorphisms in the transforming growth factor beta-inducing gene ( TGFBI ) associated with body mass index (BMI). The present invention provides 28 polymorphic sites in TGFBI , and statistical analysis for investigating the association between the 28 polymorphic sites and type 2 diabetes mellitus (T2DM) and diabetes phenotype, three SNPs ( c. 2011 + 137C> T, c.2589T> G and c.651G> C (p.L217L) provide the fact that they are associated with an obesity-related phenotype. The polymorphism / association information of the present invention is useful for pharmacogenomic studies for further genetic studies and therapeutic development of T2DM as well as other metabolic diseases. |
| priorityDate |
2005-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |